Jan Iwanczyk is listed as a director on 7 SEC Form D filings by 3 issuers between Nov 2009 and Apr 2026: Advanced Molecular Imaging, LLC (Northridge, CA — other health care — 2009–2010; $14.3M reported sold to 21 investors), Tetrous, Inc. (Sherman Oaks, CA — biotechnology — 2023–2026; $1.74M reported sold to 64 investors) and TheraCell, Inc. (Northridge, CA — biotechnology — 2010–2015; $1.34M reported sold to 25 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 17 years. Across those companies the filings report $17.4M sold in total.
Listed alongside Bradley E. Patt (7 shared filings), Frank Phillips (4 shared filings), Andy Carter (3 shared filings), Joseph M. Miller (3 shared filings), Nikhil Verma (3 shared filings) and 14 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jan. Each name links to their own page.
2 of the issuers belong to the sponsor group Advanced (3 issuers, $3.68M reported sold, 2009–2017).
What this means A sponsor group is one team that sets up a new company for each deal. Advanced has 3 companies on file and $3.68M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 7 public filings for Jan Iwanczyk and found 5 differences, 1 worth asking the sponsor about: Form D filed 393 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.